BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34380744)

  • 1. N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes.
    DelaCourt A; Black A; Angel P; Drake R; Hoshida Y; Singal A; Lewin D; Taouli B; Lewis S; Schwarz M; Fiel MI; Mehta AS
    Mol Cancer Res; 2021 Nov; 19(11):1868-1877. PubMed ID: 34380744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
    Zhu J; Warner E; Parikh ND; Lubman DM
    Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.
    Zhu J; Wu J; Yin H; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALDI imaging-based classification of hepatocellular carcinoma and non-malignant lesions in fibrotic liver tissue.
    Marquardt C; Tolstik T; Bielecki C; Kaufmann R; Crecelius AC; Schubert US; Settmacher U; Stallmach A; Dirsch O
    Z Gastroenterol; 2015 Jan; 53(1):33-9. PubMed ID: 25594705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.
    Yoon JK; Choi JY; Rhee H; Park YN
    Eur Radiol; 2022 Aug; 32(8):5119-5133. PubMed ID: 35258675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
    Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging.
    West CA; Wang M; Herrera H; Liang H; Black A; Angel PM; Drake RR; Mehta AS
    J Proteome Res; 2018 Oct; 17(10):3454-3462. PubMed ID: 30110170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry.
    Powers TW; Holst S; Wuhrer M; Mehta AS; Drake RR
    Biomolecules; 2015 Oct; 5(4):2554-72. PubMed ID: 26501333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on subtypes of hepatocellular carcinoma: From morphology to molecular.
    Vyas M; Jain D
    Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S112-S120. PubMed ID: 34135152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nondestructive molecular imaging by Raman spectroscopy vs. marker detection by MALDI IMS for an early diagnosis of HCC.
    Kirchberger-Tolstik T; Ryabchykov O; Bocklitz T; Dirsch O; Settmacher U; Popp J; Stallmach A
    Analyst; 2021 Feb; 146(4):1239-1252. PubMed ID: 33313629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays.
    Powers TW; Neely BA; Shao Y; Tang H; Troyer DA; Mehta AS; Haab BB; Drake RR
    PLoS One; 2014; 9(9):e106255. PubMed ID: 25184632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making.
    Shi Y; Wang Y; Yang R; Zhang W; Zhang Y; Feng K; Lv Q; Niu K; Chen J; Li L; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():1090324. PubMed ID: 36605944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z
    Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
    Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
    Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.
    Amin A; Bashir A; Zaki N; McCarthy D; Ahmed S; Lotfy M
    World J Gastroenterol; 2015 May; 21(20):6167-79. PubMed ID: 26034352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.
    Villanueva A; Hoshida Y; Battiston C; Tovar V; Sia D; Alsinet C; Cornella H; Liberzon A; Kobayashi M; Kumada H; Thung SN; Bruix J; Newell P; April C; Fan JB; Roayaie S; Mazzaferro V; Schwartz ME; Llovet JM
    Gastroenterology; 2011 May; 140(5):1501-12.e2. PubMed ID: 21320499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
    Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.